J Liver Cancer Search

CLOSE


Review Article

February 23, 2022


Radioembolization for hepatocellular carcinoma: what clinicians need to know
Jin Woo Choi, Hyo-Cheol Kim
J Liver Cancer. 2022;22(1):4-13.

Review Article

March 31, 2022


A clinical and pathological update on hepatocellular carcinoma
Salvatore Lorenzo Renne, Luca Di Tommaso
J Liver Cancer. 2022;22(1):14-22.

Review Article

March 17, 2022


Recent updates on the classification of hepatoblastoma according to the International Pediatric Liver Tumors Consensus
Se Un Jeong, Hyo Jeong Kang
J Liver Cancer. 2022;22(1):23-29.

Original Article

March 21, 2022


Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma
Jeong Won Jang, Ji Min Kim, Hye Seon Kim, et al.
J Liver Cancer. 2022;22(1):30-39.

Original Article

March 17, 2022


The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
Jihyun An, Hyo Jeong Kang, Eunsil Yu, et al.
J Liver Cancer. 2022;22(1):40-50.

Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors
Haeryoung Kim, Mi Jang, Young Nyun Park
J Liver Cancer. 2020;20(1):17-24.

Review Article

March 31, 2020

Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry
Jun Sik Yoon, Han Ah Lee, Jun Yong Park, et al.
J Liver Cancer. 2020;20(1):41-52.

Original Article

March 31, 2020

The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma
Sun Young Yim, Ju-Seog Lee
J Liver Cancer. 2019;19(2):97-107.

Review Article

September 30, 2019

Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry
Young Eun Chon, Han Ah Lee, Jun Sik Yoon, et al.
J Liver Cancer. 2020;20(2):135-147.

Original Article

September 30, 2020

Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
Jun Sik Yoon, Han Ah Lee, Hwi Young Kim, et al.
J Liver Cancer. 2021;21(1):58-68.

Original Article

March 31, 2021

Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma
Hye Won Lee, Kyung Joo Cho, Soon Young Shin, et al.
J Liver Cancer. 2019;19(2):108-116.

Original Article

September 30, 2019

Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma
Pil Soo Sung, Sung Woo Cho, Jaejun Lee, et al.
J Liver Cancer. 2020;20(2):128-134.

Original Article

September 30, 2020

Liver Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance
So Hyun Park, Bohyun Kim
J Liver Cancer. 2020;20(1):25-31.

Review Article

March 31, 2020

A Survey of Liver Cancer Specialists’ Views on the National Liver Cancer Screening Program in Korea
Won Sohn, Young-Sun Lee, Jae Geun Lee, et al.
J Liver Cancer. 2020;20(1):53-59.

Original Article

March 31, 2020

Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular Carcinoma
Yuri Cho, Jimin Han, Won Kim
J Liver Cancer. 2019;19(1):1-11.

Review Article

March 31, 2019

Discrepancy between the Actual Clinical Status of Patients with Hepatocellular Carcinoma and Expectations from Hepatocellular Carcinoma Surveillance: a Single-Center Study
Nak Min Kim, Young Seok Doh, Ji Woong Jang, et al.
J Liver Cancer. 2019;19(1):30-37.

Original Article

March 31, 2019

Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, et al.
J Liver Cancer. 2022;22(1):63-68.

Case Report

February 14, 2022

Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
Ahlim Lee, Jaejun Lee, Hyun Yang, et al.
J Liver Cancer. 2022;22(1):75-83.

Case Report

March 18, 2022

Concurrent transarterial radioembolization and combination atezolizumab/ bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
Min Kyung Park, Su Jong Yu
J Liver Cancer. 2022;22(1):69-74.

Case Report

March 21, 2022

Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, et al.
J Liver Cancer. 2022;22(1):84-90.

Case Report

March 22, 2022

Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma
Chai Hong Rim
J Liver Cancer. 2021;21(2):113-123.

Review Article

August 11, 2021

Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
Bo Hyun Kim, Joong-Won Park
J Liver Cancer. 2021;21(2):124-138.

Review Article

September 30, 2021

Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma
Hyuk Moon, Simon Weonsang Ro
J Liver Cancer. 2021;21(1):1-11.

Review Article

March 31, 2021

Update on Pathologic and Radiologic Diagnosis of Combined Hepatocellular-Cholangiocarcinoma
Hyungjin Rhee, Jae Hyon Park, Young Nyun Park
J Liver Cancer. 2021;21(1):12-24.

Review Article

March 31, 2021

External Beam Radiotherapy for Hepatocellular Carcinoma: a Review of the Current Guidelines in the East and the West
Sang Min Yoon
J Liver Cancer. 2021;21(1):25-33.

Review Article

March 31, 2021

A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
Jae Won Song, Ho Soo Chun, Jae Seung Lee, et al.
J Liver Cancer. 2021;21(1):69-75.

Case Report

March 31, 2021

Validation of the Korean Liver Cancer Association-National Cancer Center 2018 Criteria for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using Magnetic Resonance Imaging
Sunyoung Lee, Myeong-Jin Kim
J Liver Cancer. 2020;20(2):120-127.

Original Article

September 30, 2020

Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma
Su Jong Yu, Tim F. Greten
J Liver Cancer. 2020;20(1):1-16.

Review Article

March 31, 2020

Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
Jaewoong Kim, Jin Won Chang, Jun Yong Park
J Liver Cancer. 2020;20(1):72-77.

Case Report

March 31, 2020

Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma
Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, et al.
J Liver Cancer. 2019;19(2):136-142.

Case Report

September 30, 2019

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Young Youn Cho, Young Hwan Choi, Su Jong Yu, et al.
J Liver Cancer. 2019;19(2):128-135.

Original Article

September 30, 2019

Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma
Jong Man Kim
J Liver Cancer. 2019;19(2):85-90.

Review Article

September 30, 2019

Conventional Chemoembolization for Hepatocellular Carcinoma: Role of Cone-Beam Computed Tomography Guidance
In Joon Lee, Jin Wook Chung
J Liver Cancer. 2019;19(1):19-29.

Review Article

March 31, 2019

High-dose versus Low-dose 5-Fluorouracil and Cisplatin Based Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma
Chae-June Lim, Ji-Yun Hong, Yang-Seok Ko, et al.
J Liver Cancer. 2019;19(1):38-45.

Original Article

March 31, 2019

Effect of PTEN Polymorphism on the Development of Hepatitis B Virus-associated Hepatocellular Carcinoma
Soon Sun Kim, Jung Woo Eun, Hyo Jung Cho, et al.
J Liver Cancer. 2019;19(1):46-54.

Original Article

March 31, 2019

  • KoreaMed
  • KoMCI
  • GoogleScholar
  • DOAJ
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID

ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR AUTHORS AND REVIEWERS
Editorial Office
1521 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2022 by The Korean Liver Cancer Association.

Developed in M2PI

Close layer
prev next
Close layer
prev next